FDA Withdraws Approval of Watson Laboratories' Prescription Pain Medications Containing High Levels of Acetaminophen

Summary

The Food and Drug Administration (FDA) is withdrawing approval of an abbreviated new drug application (ANDA) for prescription pain medications containing more than 325 milligrams of acetaminophen, submitted by Watson Laboratories, Inc. (Watson), which has voluntarily requested the withdrawal of approval.